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Abstract 
Psychosis risk and mania risk scales are strongly correlated, and both psychosis and 
mania are linked to alterations in striatal dopamine. However, previous research has not 
examined whether measures of psychosis and mania risk form distinct factors or whether 
they are differentially related to other measures of psychopathology risk or to a measure 
reflecting increased striatal dopamine. In the current study with undergraduate students 
(N = 596), participants completed both psychosis risk and mania risk scales as well as 
scales assessing related psychopathology (i.e., negative and disorganized schizotypy; 
self-reported manic-like episodes). Additionally, I measured spontaneous eye blink rate 
(sEBR), which has been consistently associated with striatal dopamine levels. As 
expected, psychosis risk and mania risk factors were strongly correlated (factor 
correlation = .73). However, a two-factor confirmatory factor analytic model with 
psychosis risk and mania risk as separate factors fit significantly better than a one-factor 
risk model. Additionally, after removing shared variance, only psychosis risk was 
positively associated with both negative and disorganized schizotypy measures, and only 
mania risk was significantly related to self-reported manic-like episodes. Furthermore, 
psychosis risk and mania risk were differentially associated with sEBR. Specifically, 
psychosis risk was associated with decreased sEBR, and mania risk was associated with 
increased sEBR. Overall, these results suggest that psychosis risk and mania risk can be 
distinguished as separate factors and that they might be differentially associated with 
striatal dopamine measure.
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Differentiating Psychosis Risk and Mania Risk Scales and 
Their Associations with Spontaneous Eye Blink Rate 
 Psychosis involves symptoms such as delusions and hallucinations, whereas 
mania involves distinct periods of dramatically elevated moods and concomitant changes 
in behavior (American Psychiatric Association, 2013). There are a number of self-report 
scales that attempt to assess either psychosis or mania risk, and there are multiple reasons 
that researchers use these scales. First, it has long been thought that research on these risk 
scales might help us understand the nature of psychosis and mania risk (e.g., Barrantes-
Vidal, Grant, & Kwapil, 2015; Debbané et al., 2015; Eckblad & Chapman, 1986). 
Additionally, it has been thought that research on these scales might help us understand 
extreme variation in common personality traits that might be present in personality 
disorders (Krueger & Markon, 2014; Schalet, Durbin, & Revelle, 2011; Watson, Stasik, 
Ro, & Clark, 2013). Finally, researchers and clinicians attempting to assess people at 
clinical high risk often use these scales as screening instruments to initially identify 
people in need of an additional in-depth risk assessment (Kline & Schiffman, 2014). 
Hence, research further examining the construct validity of psychosis and mania risk 
scales could be useful for several reasons. A potentially critical gap in research on these 
scales is that previous research has rarely examined whether psychosis and mania risk 
scales can be differentiated from each other (Preti et al., 2015). Thus, the current research 
examined whether psychosis and mania risk scales formed distinct factors in a 
confirmatory factor analysis, whether these factors were differentially related to other 
measures of psychopathology risk, and whether these factors were differentially related to 
a measure reflecting increased striatal dopamine.  
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 There are several reasons why it is important to examine whether psychosis and 
mania risk scales can be differentiated. First, there is evidence that psychosis and mania 
risk scales are highly correlated. For instance, several studies examining correlations in 
the general population (N = 1095; Claridge et al., 1996), in college students (Ns = 515, 
657, & 625; Applegate, El-Deredy, & Bentall, 2009; Eckblad & Chapman, 1986; 
Schuldberg, 1990) or in a sample of artists (N = 100; Nelson & Rawlings, 2010) have 
found correlations ranging from .43 to .64, with these correlations being close to or in the 
range for how strongly psychosis risk scales correlate with each other (e.g., Cicero & 
Kerns, 2010a; 2010b). Second, there is evidence that elevated psychosis risk scores might 
predict future manic episodes about as strongly as they do future psychotic disorders 
(Chapman et al., 1994). Third, there is evidence that mania risk also predicts increased 
future psychotic-like experiences (Kwapil et al., 2000; Walsh, DeGeorge, Barrantes-
Vidal, & Kwapil, 2015). Hence, although it was expected in the current research that 
psychosis and mania scales would be differentiated, the strong associations between 
psychosis and mania risk suggest that it is important to empirically examine this 
relationship directly. In fact, there is evidence in previous research that some psychosis 
risk scales could not be easily differentiated from another related risk construct (i.e., 
dissociation; Cicero & Kerns, 2010b), further arguing for the need to directly examine 
whether psychosis and mania risk scales could be differentiated.  
 Another reason why it is important to examine whether psychosis and mania risk 
scales can be differentiated is that in addition to these risk scales being highly correlated, 
there is also a long line of evidence demonstrating that psychotic and manic disorders are 
highly related. For instance, psychotic and mood disorders are highly comorbid, with a 
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majority of individuals with so-called non-affective psychotic disorders experiencing 
mood episodes less than 50% of the time (American Psychiatric Association, 2013). 
Similarly, about half of all people with Bipolar Disorder also present with psychotic 
symptoms during their illness (Dunayevich & Keck, 2000). Furthermore, many 
individuals are diagnosed with schizoaffective disorder because they have at least one 
period where they only experience psychosis plus an extensive history of experiencing 
mood episodes (American Psychiatric Association, 2013). Consistent with this extensive 
comorbidity between psychosis and mania, family history studies have found that genetic 
risk for psychotic disorders predicts increased risk for Bipolar Disorder and vice versa 
(e.g., Lichtenstein et al. 2009). In addition, a recent GWAS study found a large overlap 
between common alleles related to non-affective psychotic disorders (i.e., Schizophrenia) 
and Bipolar Disorder (genetic correlation r = .68; Cross-Disorder Group of the 
Psychiatric Genomics Convention, 2013). Given this evidence, some have argued that the 
categorical distinction between non-affective psychotic disorders and Bipolar Disorder 
may not be valid (e.g., Craddock, O’Donovan, & Owen, 2005). In fact, an argument 
could be made that the disorder most closely related to non-affective psychosis is Bipolar 
Disorder. Given the extensive relationships between psychosis and mania, this makes it 
even more important to directly examine whether psychosis and mania risk scales can be 
differentiated.  
 A final reason why it might be important to examine whether psychosis and 
mania risk scales can be differentiated is that both psychosis and mania have been linked 
to the same neurobiological mechanism: striatal dopamine. For instance, medication that 
blocks dopamine D2 receptors, with D2 receptors most prevalent in the striatum (Hisahara 
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& Shimohama, 2011), is the only effective medication for psychosis (Seeman, 2010) and 
is also at least as effective as any other medication for the treatment of acute mania 
(Scherk, Pajonk, & Leucht, 2007). Further, increased striatal dopamine is the best-
established neurobiological correlate of psychosis (e.g., Howes et al., 2012). In addition, 
mania is associated with alterations in the Behavioral Activation System (BAS; Alloy et 
al., 2012; Johnson, Edge, Holmes, & Carver, 2013), which has long been linked to striatal 
dopamine (Beaver et al., 2006; Lawrence & Brooks, 2014). Hence, potentially an 
important issue in differentiating psychosis and mania risk scales is to examine whether 
psychosis and mania risk are differentially associated with a measure related to striatal 
dopamine levels.  
A physiological measure that has been consistently associated with striatal 
dopamine levels is spontaneous eye blink rate (sEBR). It is thought that the brain has a 
spontaneous blink generator (e.g., to help maintain eye moisture), with some evidence 
that the spinal trigeminal complex might be involved (Kaminer, Powers, Horn, Hui, & 
Evinger, 2011). The striatum/basal ganglia is known to regulate spinal trigeminal 
complex activity, suggesting that striatal dopamine levels could then affect sEBR. 
Consistent with this, a long line of animal and human research has found evidence that 
striatal dopamine functioning is related to sEBR, with decreased dopamine being 
associated with a decrease in sEBR and increased dopamine being associated with an 
increase in sEBR (Cavanagh, Masters, Bath, & Frank, 2014; Slagter, Georgopoulou, & 
Frank, 2015). For instance, Parkinson’s Disease, which involves decreased striatal 
dopamine, is associated with decreased sEBR (Karson, 1983). In contrast, there is 
evidence that sEBR is increased in people with psychotic disorders (Karson, Dykman, & 
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Paige, 1990; Kleinman et al., 1984). Furthermore, animal evidence has consistently found 
that striatal dopamine manipulations affect sEBR (Groman et al., 2014; Kleven & Koek, 
1996). Therefore, if psychosis and mania risk scales are differentially associated with 
striatal dopamine levels, then it might be expected that these scales would be 
differentially associated with sEBR.  
Thus, the current research examined whether psychosis and mania risk scales 
could be differentiated from each other. If they could, then it would be expected that even 
though psychosis and mania risk scales might be strongly correlated, that they would still 
form distinct factors in a confirmatory factor analysis. In the current research, I examined 
whether a 2-factor psychosis risk and mania risk model fit significantly better than a 1-
factor model that included all psychosis and mania risk scales.  
If psychosis and mania risk scales could be differentiated from each other, then it 
would also be expected that these risk scales would be differentially associated with other 
scales reflecting psychopathology risk and symptoms. In particular, one expectation is 
that only psychosis risk scales would be associated with other measures of schizotypy. 
Schizotypy refers to traits that reflect symptoms of schizophrenia but in a diminished 
form (Raine, 2006), with research suggesting at least three distinct general facets of 
schizotypy—positive/psychosis risk (i.e., scales measuring delusion-like and 
hallucination-like experiences reflecting psychosis risk), negative, and disorganized 
(Kerns, 2006). Studies have found that both negative and disorganized schizotypy are 
positively correlated with psychosis risk (e.g., Cicero & Kerns, 2010b). On the other 
hand, at least one study has found that a mania risk scale was not associated with a 
measure of negative schizotypy (Applegate, El-Deredy, & Bentall, 2009). In the current 
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study, it was expected that after removing shared variance that only psychosis risk would 
be associated with measures of negative and disorganized schizotypy.  
In contrast, another expectation is that after removing shared variance that only 
mania risk would be associated with measures of self-reported prior experience of manic-
like episodes. Consistent with this, mania risk scales have been found to not only predict 
future Bipolar Disorder but to also identify people with a previous history of hypomanic 
or manic episodes. However, to my knowledge previous research has not examined 
whether after removing shared variance that only mania risk but not psychosis risk would 
be associated with measures of prior manic-like episodes.  
Finally, if psychosis and mania risk scales could be differentiated from each other, 
then it would also be expected that these risk scales would be differentially associated 
with sEBR. Again, previous research and theory suggest that both psychosis risk and 
mania risk might be associated with an increase in striatal dopamine. However, there are 
also reasons to think that psychosis risk scales might be associated with a decrease in 
striatal dopamine. There is evidence that striatal dopamine is only increased during acute 
psychotic episodes, but that striatal dopamine may not be increased when not in an acute 
psychotic episode (Laruelle, Abi-Dargham, Gil, Kegeles, & Innis, 1999). Further, 
psychosis risk scales do not directly assess current symptoms but instead enquire about 
trait levels of psychotic-like beliefs and experiences. Finally, there is evidence that if 
anything, psychotic disorders might be associated with low levels of trait striatal 
dopamine (Maia & Frank, 2017). For instance, there is consistent evidence that psychotic 
disorders and genetic risk for psychotic disorders are associated with decreased activation 
in the limbic striatum (meta-analysis by Radua et al., 2015), which is consistent with 
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psychosis risk being associated with decreased trait dopamine. Hence, if psychosis and 
mania risk scales can be differentiated from each other, then it might also be expected 
that these risk scales would be differentially associated with sEBR, with psychosis risk 
being associated with decreased sEBR and mania risk being associated with increased 
sEBR.  
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METHODS 
Participants 
Participants (N = 639) were undergraduates at University of Missouri enrolled in 
an Introduction to Psychology course. Participants (n = 23) who scored 3 or greater on a 
13-item infrequency scale (Chapman & Chapman, 1986), which measures careless and 
invalid responding (e.g., I cannot remember a time when I talked with someone who 
wore eyeglasses). In addition, one participant with invalidly fast questionnaire responses 
and noted by research assistants as not paying attention as well as participants (n = 4) 
who exhibited very poor performance on a very simple cognitive task (accuracy < 65% 
on a task involving deciding whether two cards were the same or different) were also 
excluded. Lastly, 15 participants were excluded for not completing all questionnaire 
measures; as can be seen in Table 1, this resulted in a final sample size of 596 
participants.  
Measures  
Psychosis Risk Questionnaires. Participants completed five different psychosis 
risk questionnaires. The Perceptual Aberration Scale (PerAb; Chapman, Chapman, & 
Raulin, 1978; α = .81 in current study; note that questionnaire reliabilities were uniformly 
high in the current study, with all α’s ≥ .80) is a 35-item true/false scale that assessed 
perceptual distortions about one’s body. A second questionnaire was the Magical Ideation 
Scale (MagicId; Eckblad & Chapman, 1983; α = .81), a 30-item true/false scale that 
assessed ‘‘beliefs in forms of causation that by conventional standards are invalid’’ 
(Eckblad & Chapman, 1983; p. 215). Individuals scoring high on PerAb and MagicId 
scales have been found to be at increased risk for a future psychotic disorder (Chapman et 
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al., 1994). The third was the Cardiff Anomalous Perceptions Scales (CAPS; Bell, 
Halligan, & Ellis, 2006; α = .89), a 32-item yes/no scale that assessed psychosis 
experiences, olfactory and gustatory experiences, and temporal lobe disturbance 
experiences. For items that participants endorsed as having experienced, participants then 
also rated frequency, distress, and intrusiveness on a five-point Likert-scale. Previous 
studies have looked at the CAPS using four scores separately: number of items endorsed, 
sum of distress ratings for items endorsed, sum of intrusiveness ratings for items 
endorsed, and sum of frequency ratings for items endorsed. In the current study, all of 
these 4 scores were strongly correlated with each other, rs ≥ .93. Hence, I created a single 
composite CAPS score by standardizing and averaging these four scores together. The 
CAPS has been found to be highly correlated with other psychosis risk scales (e.g., O-
Life Unusual Experiences Subscale r = .57; Peters Delusions Inventory r = .60; Launay-
Slade Hallucinations Scale r = .65), and it has been found that inpatients with psychosis 
scored significantly higher compared to a sample from the general population (Bell et al., 
2006). The fourth questionnaire was the Positive Symptoms subscale of the Prodromal 
Questionnaire-Likert (PQ-Likert Pos; α = .91; Loewy, Johnson, & Cannon, 2007), a 45-
item scale that assessed the occurrence, frequency (5-point Likert scale, from 0 to Daily), 
and distress (true/false) of psychotic-like beliefs and experiences. PQ-Likert Pos 
frequency and distress scores were highly correlated with each other, r = .82. Hence, I 
created a single composite PQ-Likert Pos score by averaging standardized frequency and 
distress scores. The PQ-Likert Pos has been found to significantly predict interview 
assessment of probable high imminent risk of psychotic disorder onset (Loewy, Bearden, 
Johnson, Raine & Cannon, 2005). The last psychosis scale was the Psychoticism 
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Personality Traits Domain from the Personality Inventory for DSM-5 (PID-5; Krueger, 
Derringer, Markon, Watson, & Skodol, 2012; α = .95). The Psychoticism Domain 
subscale consisted of 33 Likert-rated items (0 = Very False or Often False to 3 = Very 
True or Often True), which assessed psychoticism facets related to eccentricity, 
perceptual dysregulation, and unusual experiences. A previous study found that a group 
with psychotic disorder scored significantly higher on the PID-5 Psychoticism Domain 
subscale compared to a control group, with the Psychoticism Domain also being 
moderately correlated with current psychotic symptom severity (Bastiaens et al., 2017).  
 Mania Risk Questionnaires. Participants also completed two mania risk 
questionnaires: the General Behavior Inventory 10-Item Mania Scale (GBI; Youngstrom, 
Frazier, Demeter, Calabrese, & Findling, 2008) and the Hypomanic Personality Scale 
(HPS; Eckblad & Chapman, 1986). The GBI 10-Item Mania Scale (α = .84) consisted of 
Likert-rated items (0 = Never/Hardly Ever to 3 = Very Often), which assessed both 
hypomanic and biphasic behaviors (i.e., behaviors fluctuating between depression and 
hypomania). The 10 items used in the current research were from the larger original 
version of the GBI (Depue, Krauss, Spoont, & Arbisi, 1989), with these 10 items found to 
best discriminate pediatric Bipolar Disorder in youth up to age 17 (Youngstrom, Frazier, 
Demeter, Calabrese, & Findling, 2008) and found to correlate highly with the original 
GBI (r = .95).  
The HPS (α = .86) is a 48-item true/false scale that was constructed to identify 
individuals who were predisposed to experience episodes of hypomanic euphoria as well 
as to develop Bipolar Disorder. Eckblad and Chapman (1986) reported that the 
overwhelming majority of people scoring high on the HPS had a history of hypomanic 
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episodes but without a history of manic episodes. In a 13-year follow-up study of 
individuals, who scored high on the HPS, 25% of the high scoring group met criteria for 
Bipolar Disorder compared to 0% of controls (Kwapil et al., 2000). Consistent with most 
previous research using this scale (e.g., Fulford, Feldman, Tabak, McGillicuddy, & 
Johnson, 2013; Kwapil et al., 2000, Walsh, DeGeorge, Daniella, Barrantes-Vidal, & 
Kwapil, 2015), the HPS total score was used in the main analyses.  
Negative and Disorganized Schizotypy Traits. To examine convergent and 
discriminant associations of psychosis and mania risk scales, participants also completed 
measures of negative and disorganized schizotypy. To assess negative schizotypy, 
participants completed the Revised Social Anhedonia Scale (SocAnh; α = .82; Eckblad, 
Chapman, Chapman, & Mishlove, 1982) as well as the PQ-Likert Negative Symptoms 
subscale (PQ-Likert Neg; α = .89; Loewy, Johnson, & Cannon, 2007). SocAnh is a 40-
item true/false scale that assessed lack of social contact and lack of social pleasure and 
has been found to predict future onset of non-psychotic schizophrenia-spectrum disorders 
(Gooding et al., 2005; Kwapil, 1998). The PQ-Likert Neg is a 19-item Likert scale that 
assessed the frequency of (5-point Likert scale, from 0 to Daily) and distress (true/false) 
associated with negative symptoms. To assess disorganized schizotypy, participants 
completed the PQ Disorganized Symptoms subscale (PQ-Likert Disorg; α = .80; Loewy 
et al., 2007), a 13-item measure that assessed the frequency of (5-point Likert scale, from 
0 to Daily) and distress (true/false) associated with disorganized symptoms. To account 
for both symptoms endorsed and distress, PQ-Likert Neg and PQ-Likert Disorg scores 
were calculated by summing their respective standardized frequency and distress scores. 
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Manic-Like Episode Questionnaires. To further examine convergent and 
discriminant associations of psychosis and mania risk scales, participants also completed 
two questionnaires that assessed previous manic-like episodes: the WHO Composite 
International Diagnostic Interview 3.0 (CIDI; Kessler et al., 2006) and the Mood 
Disorder Questionnaire (MDQ; Hirschfeld et al., 2000). The CIDI is a yes/no interview 
that assessed to what extent people reported previous manic-like episodes. For the 
purposes of this study, participants completed the interview on the computer as a 
questionnaire. This measure first asks about whether the participant experienced periods 
of euphoria or irritability. If the participant responded yes, then the participant was asked 
whether they experienced any of up to nine symptoms during those periods (e.g., “Did 
you spend so much more money than usual that it caused you to have financial 
trouble?”). Participants who then endorsed at least six items were considered at moderate 
risk for having had a manic-like episode/meeting criteria for a Bipolar Disorder (although 
note that this scale has not been used in previous research with undergraduate college 
students). This measure has been shown to have good concordance with the Structured 
Clinical Interview for DSM-IV Axis I Disorders (SCID), an established interview 
measure of bipolar-spectrum disorders, with the scale detecting 67% – 96% of true cases 
and with a predictive value of 31% – 52% (Kessler et al., 2006).   
Participants also completed the MDQ, a true/false scale that assesses past manic-
like episodes. On the MDQ, participants first reported whether they had experienced any 
of 13 manic-like symptoms (e.g., “you got much less sleep than usual and found you 
didn’t really miss it?”). Then individuals rated whether several of these symptoms had 
occurred during the same time period. Finally individuals were asked whether any 
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symptoms had caused problems for them. The MDQ has been shown to have high 
specificity (.90) and high sensitivity (.73) in an outpatient population diagnosed with a 
mood disorder (Hirschfeld et al., 2000). In contrast, it has been shown to have high 
specificity (.97) but low sensitivity (.28) in a general population (Hirschfeld et al., 2003). 
In particular, it has been suggested that the MDQ’s requirement that manic symptoms 
cause impairment might prevent the MDQ from effectively detecting Bipolar II Disorder 
because Bipolar II involves hypomanic episodes that do *not* cause significant 
impairment (Miller, Johnson, Kwapil, & Carver, 2011; note that in contrast, Bipolar I is 
defined as involving manic episodes that do cause significant impairment; American 
Psychiatric Association, 2013). Consistent with this, in the validation study of the MDQ 
in a general population (Hirschfeld et al., 2003), the authors found unexpectedly lower 
rates of Bipolar II Disorder, compared to Bipolar I Disorder, in their sample. Thus in the 
current study, in line with previous studies (e.g., Hirschfeld et al., 2000; Hirschfeld et al., 
2003), manic-like episodes were indicated both by endorsing at least 7 of the 13 items 
and by indicating that several of these symptoms had occurred during the same time 
period. However, based on previous research, I omitted the requirement that these 
symptoms cause impairment. Overall, it was expected that mania risk would be more 
associated than psychosis risk with evidence of previous manic-like episodes.  
General Distress and Current Mood. Participants also completed measures 
related to general distress and current mood to examine: (a) whether current distress or 
mood was differentially associated with psychosis or mania risk and (b) whether 
differences in current general distress or mood could possibly account for relationships 
between psychosis and mania risk with the other questionnaires and with sEBR. General 
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distress was assessed with the PQ-Likert General Symptoms subscale (PQ-Likert Gen; α 
= .88; Loewy et al.; 2007), a 15-item measure that assessed the frequency of (5-point 
Likert scale, from 0 to Daily) and distress (true/false) associated with psychological 
distress (e.g., depression-like symptoms) and problems in role functioning. A PQ-Likert 
Gen score was obtained by summing standardized frequency and distress scores. Current 
mood (Barrett & Russell, 1999) was assessed with a 16-item Likert-rated scale (0 = Not 
at All to 6 = Extremely Strongly). The scale consisted of 8 positive items (e.g., happy, 
excited, calm; α = .77) and 8 negative items (e.g., upset, depressed; α = .81). Total scores 
for positive mood and negative mood were used in analyses. 
Spontaneous Eye Blink Rate. To measure trait dopamine (Slagter, 
Gerogopoulou, & Frank, 2015), sEBR was measured by videotaping participants as they 
looked at a fixation cross on a blank poster board for six minutes in accordance with a 
well-validated procedure of sEBR data collection (Colzato, Slagter, van den Wildenberg, 
& Hommel, 2009; Chermahini & Hommel, 2010). sEBR was calculated as the average 
number of blinks across the six minutes. As Barbato and colleagues (2000) have found 
that dopamine levels increase after 5:00 P.M., sEBR data were not collected past 5:00 
P.M. Additionally, as contacts could irritate the eyes and result in increased blink rates, 
all participants with contacts were asked to wear their glasses during the current study. 
  From these video recordings, research assistants calculated the participants' sEBR. 
As this study did not use electrooculography (EOG) to measure sEBR, the first author of 
this article piloted the reliability of video assessment ratings on 10 undergraduates. 
Participants’ blink rates were simultaneously measured with EOG and video recordings. 
My ratings of video recorded sEBR were reliable (ICC = 1.00) and virtually identical to 
PSYCHOSIS AND MANIA RISK WITH STRIATAL DOPAMINE 
	 15	
EOG recordings. Furthermore, 20 research assistants were trained to rate sEBR by rating 
a subset of 10 participant videos, and the research assistants reached a high level of 
interrater reliability with my ratings (ICC = .94). During the data collection phase of the 
study, videos that were deemed difficult to rate were rated by multiple research assistants. 
If the ratings between the two research assistants varied by more than 10 blinks across the 
6 minutes, the data (n = 2) were not included in the analyses. Note that if I divided up the 
sEBR into six 1-minute intervals, these six scores exhibited a high level of reliability (α = 
.97).  
Procedure  
 The duration of the study was 90 minutes. All questionnaire and task measures 
were administered in E-Prime 2.0 (Psychology Software Tools, 2012). Upon arrival to 
the study and after obtaining informed consent, participants first completed the current 
mood questionnaire and then sEBR data was obtained. Following this, participants 
completed the questionnaires in the current study in two different blocks. In the first 
questionnaire block, participants completed the measures in the following order: (1) 
Wisconsin Schizotypy Scales (consisting of a mixture of PerAb, MagicId, SocAnh, and 
infrequency scale items); (2) GBI; (3) CAPS; and (4) HPS. In the second questionnaire 
block, participants completed the measures in the following order: (1) PQ-Likert 
(consisting of a mixture of PQ-Likert Pos, PQ-Likert Neg, PQ-Likert Disorg, and PQ-
Likert General Symptoms); (2) MDQ; (3) PID-5; and (4) CIDI. Note again that 
questionnaire scale internal reliabilities for the psychosis and mania risk scales in the 
current study were uniformly high (all αs > .80). Additionally, in the current study 
participants completed several computerized behavioral tasks, in particular multiple 
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versions of the Weather Prediction Task (WPT), which was previously found to be 
associated with psychosis risk (Karcher, Martin, & Kerns, 2015). In this study, I did not 
find an association between psychosis risk and WPT performance. However, 
performance on the WPT, which can be a challenging and effortful task, was quite poor 
in the current study. The WPT should produce a clear and strong learning effect over 
time; however in the current study a learning effect was virtually absent (current study 
accuracy by task quartile 55%, 60%, 61%, & 61%; in contrast, accuracy by quartile in 
Karcher et al., 2015: 59%, 69%, 72%, & 76%; similarly in Gluck et al., 2002: accuracy 
near 50% accuracy in Quartile 1 versus > 70% accuracy by Quartile 4). Thus, it is unclear 
whether the current WPT data provide a valid test of whether WPT performance is 
associated with either psychosis risk or mania risk. Complete details of WPT task 
administration and all WPT results are included in the Supplemental Materials and 
Results.	
Analyses 
Data were analyzed with a series of structural equation models using Mplus 7 
(Muthén & Muthén, 1998-2015). First, I determined the best-fitting structural equation 
model involving psychosis risk and mania risk scales. The manifest variable that loaded 
highest on each latent variable was included first in the model, which set the standardized 
factor loadings to be equal to one. As all of the manifest variables were continuous and 
distributions were non-normal, MLR estimators were used to fit the model. MLR are 
maximum likelihood parameter estimates with robust standard errors and a chi-square 
test statistic that is robust to non-normality. Model fit was evaluated using three test 
statistics: the comparative fit index (CFI), Tucker-Lewis index (TLI), and the root mean 
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square error of approximation (RMSEA). Chi-square difference tests of model 
comparisons were done using the Satorra-Bentler scaled chi-square (Satorra & Bentler, 
2010). Lastly, to examine differential validity of psychosis risk and mania risk, I used 
structural equation modeling to examine psychosis risk and mania risk factors as joint 
predictors of other variables (e.g., sEBR). Given sizable sex differences on multiple 
scales, consistent with previous research I standardized all measures within sex (e.g., 
Bell, Halligan, & Ellis, 2006; Eckblad & Chapman, 1986; Kerns, 2006).  
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RESULTS 
Factor Structure of Psychosis Risk and Mania Risk 
As can be seen in Table 2, as expected, the psychosis risk measures were highly 
correlated with each other, the mania risk measures were also highly correlated with each 
other, and at the same time all correlations between the psychosis risk and mania risk 
measures were moderate to large in size. Next, I used confirmatory factor analyses to 
examine if psychosis risk and mania risk could be distinguished as two distinct factors. 
Model 1 included a single general risk factor with all psychosis risk scales (i.e., CAPS, 
PerAb, MagicId, PQ-Likert Pos, and PID-5) and all mania risk scales (i.e., GBI and HPS) 
loading on just one factor. Model 1 did not provide an adequate fit, χ2 (14, N = 596) = 
140.97, p < .001, CFI = .91, TLI = .86, RMSEA = .12. Acs can be seen in Figure 1, 
Model 2 included two factors with psychosis risk and mania risk scales loading on 
separate factors. In contrast to the single factor Model 1, the two factor Model 2 provided 
a more adequate fit, χ2 (13, N = 596) = 92.64, p < .001, CFI = .96, TLI = .93, RMSEA = 
.09, with Model 2 providing significantly better fit than Model 1, χ2 (1, N = 596) = 65.68, 
p < .01.  
Associations between Risk Factors with Symptoms and Mood 
Next, I examined whether the distinct psychosis risk and mania risk factors were 
differentially associated with other self-reported symptom measures and with self-
reported current mood. As can be seen in Table 3, as expected, only psychosis risk was 
positively associated with both negative schizotypy (including social anhedonia) 
measures and with a disorganized schizotypy measure. I further examined whether 
common-method variance could account for some of these associations with psychosis 
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risk. In particular, note that the PQ-Likert subscales were highly correlated with each 
other (rs ranging from .75 to .82). Hence, I repeated these analyses after removing the 
PQ-Likert Pos scale from the model, finding similar results (associations with psychosis 
risk & mania risk: for PQ-Likert Neg .48 & .15; for PQ-Likert Disorg .57 & .07) Hence 
only psychosis risk but not mania risk was associated with negative and disorganized 
schizotypy. In contrast, as can be seen in Table 3, for self-reported manic episodes, only 
the mania risk factor was significantly associated with reporting manic-like episodes on 
both the CIDI and the MDQ. Hence, there was evidence that only the mania risk factor, 
but not the psychosis risk factor, was associated with manic-like episodes. 
For current general distress (i.e., PQ-Likert Gen), both psychosis and mania risk 
were associated with increased current general symptoms (note that if I removed PQ-
Likert Pos, associations were .21 & .40 for psychosis risk & mania risk, respectively; 
both ps < .001). For current mood, neither psychosis risk nor mania risk were associated 
with current positive mood. However, only mania risk was significantly associated with 
increased current negative mood. In addition, note that current mood was associated with 
negative and disorganized schizotypy and with self-reported manic-like episodes. 
However, after removing shared variance with current mood, associations between 
psychosis and mania risk with schizotypy facets and manic-like episodes were very 
similar. 
Associations between Risk Factors and Spontaneous Eye Blink Rate 
 Next, I examined whether psychosis risk and mania risk were differentially 
associated with sEBR. As can be seen in Table 3, I found that psychosis risk was 
significantly associated with decreased sEBR. In contrast, mania risk was significantly 
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associated with increased sEBR. Hence, psychosis risk and mania risk were differentially 
associated with sEBR. Further, note that current mood was not associated with sEBR. 
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DISCUSSION 
Psychosis and mania risk scales have been used in research and in clinical 
practice to identify individuals at risk for psychotic or mania disorders. However, few 
studies have examined whether these scales can be differentiated from each other, even 
though previous research has found that (1) psychosis and mania risk scales are often 
highly correlated; (2) psychotic and manic disorders are highly related; (3) and both 
psychosis and mania might be related to the same neurobiological mechanism, striatal 
dopamine. In the current study, I found evidence that psychosis and mania risk scales 
form two distinct risk factors. In addition, psychosis and mania risk were also 
differentially related to other measures of psychopathology and current mood as well as 
to a measure related to striatal dopamine (i.e., sEBR). Thus, this study provides novel 
evidence that psychosis risk and mania risk can be differentiated from each other.  
If psychosis and mania risk scales can be differentiated from each other, then it 
would be expected that these scales would form distinct factors in a confirmatory factor 
analysis. In the current study, as predicted, psychosis and mania risk scales were 
moderately to highly correlated with each other, and distinct psychosis and mania risk 
factors were highly associated with each other. However in a confirmatory factor 
analyses, a two-factor risk model with separate psychosis and mania risk factors did fit 
significantly better than a one-factor risk model. Little previous research has examined 
whether psychosis and mania risk scales form separate factors. One previous study 
reported evidence of distinct psychosis and mania risk scale factors (Preti et al., 2015), 
however there could be questions about whether that study truly assessed a mania risk 
factor (e.g., arguably only one mania risk scale amongst an otherwise heterogeneous mix 
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of negative affect scales). In any event, the current study provides novel evidence that 
psychosis risk and mania risk scales form distinct factors. 
Although the current study found novel evidence for distinct factors, future 
research could continue to examine whether psychosis and mania risk factors are distinct. 
For instance, although the current research found a two-factor model fit significantly 
better than a one-factor model, the two-factor model did not meet all possible criteria for 
a well-fitting model (e.g., RMSEA < .06; Hu & Bentler, 1999). I suspect that part of the 
reason for this is that the psychosis risk scales used in this study might ultimately load 
onto more than one separate but highly correlated psychosis risk factors. Consistent with 
this, previous research has found that psychosis risk scales do form multiple factors. For 
instance, Cicero and Kerns (2010a) found that unusual beliefs and experiences, measured 
with the same Magical Ideation and Perceptual Aberration scales used in the current 
research, loaded on a factor distinct both from a referential thinking factor and from a 
paranoia factor. Potentially consistent with this, both the psychosis risk Prodromal 
Questionnaire-Likert (i.e., PQ-Positive) and the PID-5 used in the current study refer to a 
range of psychosis risk items including unusual beliefs and experiences, referential 
thinking, and paranoid ideation. Therefore, one issue for future research is to examine 
whether a model that involves distinct psychosis risk factors as well as a mania risk factor 
would meet criteria for a well-fitting model. Another issue for future research would be 
to examine whether mania risk might also be comprised of distinct sub-factors (Schalet et 
al., 2011). Lastly, future research could examine whether psychosis and mania risk scales 
form distinct factors in treatment-seeking populations.  
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In addition to the two-factor psychosis and mania risk model fitting better than a 
single-factor model, the separate psychosis and mania risk factors were also differentially 
related to measures of psychopathology and current mood as well as to a measure of 
striatal dopamine (i.e., sEBR). Some of the specific associations for the psychosis risk 
factor after removing shared variance with mania were as expected. For instance, 
psychosis risk was thought to be at least moderately to strongly associated with other 
traits thought to reflect increased risk for schizophrenia-spectrum disorders (i.e., 
schizotypy). Consistent with this, I found that only psychosis risk, but not mania risk, was 
associated with both negative schizotypy and disorganized schizotypy. Hence, after 
removing shared variance, only psychosis risk but not mania risk was associated with 
other schizotypy facets. 
In addition, psychosis risk and mania risk were also differentially associated with 
sEBR, with psychosis risk associated with decreased sEBR and mania risk associated 
with increased sEBR. The association between psychosis risk and decreased sEBR is 
consistent with the hypothesis that psychosis risk scales would be associated with 
decreased tonic striatal dopamine. Although increased striatal dopamine has been found 
in psychotic disorders (Howes et al., 2012), there is evidence that striatal dopamine 
increases only during acute psychotic episodes (Laruelle, Abi-Dargham, Gil, Kegeles, & 
Innis, 1999; Shotbolt et al., 2011). Further, despite this episodic increase, recent evidence 
has suggested that psychotic disorders might be associated with low levels of trait striatal 
dopamine (Maia & Frank, 2017). Hence, the current results provide novel evidence that 
scales that assess trait level psychosis risk are associated with a decrease in a biomarker 
related to striatal dopamine.  
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There are several ways that future research could further examine whether 
psychosis risk is associated with decreased striatal dopamine. Most directly, future 
research could examine whether psychosis risk scales are related to striatal dopamine 
levels assessed using PET brain imaging. Interestingly, at least one study has measured 
striatal dopamine release in healthy participants and examined correlations with 
schizotypy traits thought to be related to schizophrenia-spectrum disorders (using the 
Schizotypal Personality Questionnaire), including measures of psychosis risk (Woodward 
et al., 2011). That study found evidence that schizotypy, specifically disorganized 
schizotypy, was associated with increased striatal dopamine release. On the surface, these 
results seem inconsistent with the current results. However, that previous PET study 
examined phasic dopamine release, whereas in the current study sEBR presumably 
reflects decreased tonic dopamine levels (Slagter, Georgopoulou, & Frank, 2015). 
Overall, the results of the current study and of Woodward et al. (2011) are consistent with 
the suggestion that psychotic disorders might involve a combination of both decreased 
tonic dopamine levels but increased spontaneous phasic dopamine release (Maia & 
Frank, 2017). Note also that there are striatal dopamine mechanisms that are consistent 
with decreased tonic and increased phasic dopamine (e.g., decreased tonic dopamine 
resulting in decreased activation of presynaptic dopamine autoreceptors that normally 
attempt to reduce phasic dopamine release; Grace, 2016). This suggests that an important 
issue in future research might be to directly examine how psychosis risk is associated 
with both tonic dopamine levels and phasic dopamine release in the same study. In 
addition, future research could examine other indicators related to sEBR and dopamine, 
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such as performance on behavioral tasks (Cavanagh, Masters, Bath, & Frank, 2014; 
Groman et al., 2014; Slagter, Georgopoulou, & Frank, 2015).  
In contrast to psychosis risk, mania risk had a different pattern of associations 
with other variables. Although mania risk as expected was not associated with other 
facets of schizotypy, mania risk was associated with self-reported manic-like episodes on 
both the CIDI and the MDQ. Hence, as expected, only mania risk measures were 
associated with a measure of previous manic-like episodes, consistent with previous 
research (Eckblad & Chapman, 1986; Kwapil et al., 2000). This result is also interesting 
given that psychosis risk has been found to predict future risk of manic-like episodes 
(Chapman et al., 1994). The current research suggests that the association between 
psychosis risk measures and future manic-like episodes might have been the result of 
variance shared between psychosis and mania risk scales.  
In addition, mania risk showed a very different association with sEBR than 
psychosis risk. In particular, in contrast to psychosis risk, which was associated with 
decreased sEBR, mania risk was associated with increased sEBR. This is consistent with 
the hypothesis that mania risk might be associated with increases in striatal dopamine 
(Beaver et al., 2006; Lawrence & Brooks, 2014). To date, only two studies have 
examined the relationship between mania and sEBR, and the results have been mixed. In 
a small sample study on individuals with Bipolar II Disorder with a seasonal affective 
course, Depue and colleagues (1990) found that this group exhibited elevated sEBR 
compared to a healthy control group. However, a recent study examining sEBR in 
individuals diagnosed with Bipolar I Disorder found that there was no difference in sEBR 
between the Bipolar I Disorder group and the healthy control group at baseline and 
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during a reward task (Peckham & Johnson, 2016). However, note that participants in the 
Depue et al. (1990) study were unmedicated. In contrast, in Peckham and Johnson (2016) 
more than 40% were taking antipsychotic medication that profoundly block D2 receptors 
in the striatum and could have obscured possible associations with sEBR. Hence, the 
results from the current study are consistent with previous research on unmedicated 
Bipolar Disorder and provide novel evidence that mania risk scales are associated with an 
increase in a biomarker related to tonic striatal dopamine. Further, in the current study I 
only found that mania risk was associated with sEBR after removing variance shared 
with psychosis risk. Hence, the current study suggests that in the general population that 
it is the variance that is unique to mania risk and that is not shared with psychosis risk 
that is associated with sEBR and possibly with increased tonic dopamine. 
 Future research could further examine the relationship between mania risk and 
striatal dopamine. Firstly, studies could more directly examine if there is an increase in 
striatal dopamine in mania risk. Currently, no study has directly assessed striatal 
dopamine levels (i.e., using PET brain imaging) across the different phases of Bipolar 
Disorder (i.e., euthymia, hypomania, and mania) or in individuals at risk of developing a 
bipolar-spectrum disorder. In general, it is thought that mania is associated with increased 
dopamine levels (Ashok et al., 2017; Cousins, Butts, & Young, 2009); however, it is 
unknown if this increase is specific to a certain phase or if it is present in individuals at 
risk for mania. Secondly, to further investigate the relationship between mania and 
increased striatal dopamine levels, future studies could concurrently examine the 
relationship between mania and both tonic and phasic dopamine levels.  
PSYCHOSIS AND MANIA RISK WITH STRIATAL DOPAMINE 
	 27	
 In summary, this study provided novel evidence demonstrating that not only can 
psychosis risk and mania risk be discriminated from each other, but also that these risk 
factors were differentially associated with other measures of psychopathology, mood, and 
striatal dopamine. These results suggest that though psychosis and mania risk may have 
much in common, they show differential patterns, which can help us better understand 
risk for each of these disorders. Future research could further examine if psychosis and 
mania risk measures might form even more than two factors. Additionally, future 
research could further examine the relationship between psychosis and mania risk with 
both tonic dopamine levels and phasic dopamine release (Grace, 2016; Peckham & 
Johnson, 2016).   
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Table 1 
Demographics 
Sex   
Male 47.2% 
Female 52.5% 
Age   
Mean (SD) 18.93 (0.99) 
Ethnicity  
Caucasian 78.4% 
African American 12.3% 
Asian American 2.5% 
Latino/Latina 1.8% 
American Indian/Alaska Native 0.5% 
Native Hawaiian/Other Pacific Islander 0.2% 
Biracial 2.8% 
Other 1.3% 
Missing 0.3% 
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Table 2 
Zero-Order Pearson Correlations Among Questionnaires and Spontaneous Eye Blink 
Rate 
 
Measure 1 2 3 4 5 6 7 8 
Psychosis Scales         
1. PerAb —        
2. MagicId .68** —       
3. CAPS .65** .68** —      
4. PQ-Likert Pos .53** .54** .60** —     
5. PID-5 .51** .52** .62** .65** —    
Mania Scales         
6. GBI .49** .51** .51** .51** .47** —   
7. HPS .35** .45** .40** .36** .37** .59** —  
Other Schizotypy         
8. SocAnh .34** .25** .23** .22**  .31** .06 .18** — 
9. PQ-Likert Neg .45** .41** .46** .75** .53** .17** .43** .34** 
10. PQ-Likert Disorg .44** .44** .50** .82** .60** .29** .44** .22** 
Manic-Like Episode Measures     
11. CIDI .34** .27** .27** .34** .31** .33** .34** .06 
12. MDQ No Impairment .25** .30** .33** .39** .37** .41** .34** .08* 
General Distress & Mood         
13. PQ-Likert Gen  .38** .34** .40** .66** .45** .52** .25** .19** 
14. Mood Pos -.11** .00  .03 -.05   .02 -.08 .07 -.14** 
15. Mood Neg .20** .17** .20** .29** .18** .34** .16** .06 
Physiological         
16. sEBR .02 -.01 -.05 -.01 -.07 .05 .04 .01 
 
(Continued) 
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Table 2 
Zero-Order Pearson Correlations Among Questionnaires and Spontaneous Eye Blink 
Rate (Continued) 
 
Measure 9 10 11 12 13 14 15 16 
Other Schizotypy          
9. PQ-Likert Neg —        
10. PQ-Likert Disorg .76** —       
Manic-Like Episode Measures        
11. CIDI .33** .36** —      
12. MDQ No Impairment .30** .34** .28** —     
General Distress & Mood         
13. PQ-Likert Gen  .80** .71** .32** .35** —    
14. Mood Pos -.16** -.12** -.07  -.04 -.19** —   
15. Mood Neg .37** .30** .11** .15** .48** -.19**   
Physiological       —  
16. sEBR .02 -.02 -.03  -.06 .04 -.02 .06 — 
 
Note. *Correlation is significant at p < .05; **Correlation is significant at p < .01; PerAb = 
Perceptual Aberration Scale; MagicId = Magical Ideation Scale; CAPS = Cardiff 
Anomalous Perceptions Scale; PQ-Likert Pos = Prodromal Questionnaire-Likert Positive 
Symptoms Subscale; PID-5 = Personality Inventory for DSM-5 Psychoticism Domain; 
HPS = Hypomanic Personality Scale; GBI = General Behavior Inventory; SocAnh = 
Revised Social Anhedonia Scale; PQ-Likert Neg = Prodromal Questionnaire-Likert 
Negative Symptoms Subscale; PQ-Likert Disorg = Prodromal Questionnaire-Likert 
Disorganized Symptoms Subscale; CIDI = WHO CIDI 3.0 Bipolar Screening Scales; 
MDQ = Mood Disorder Questionnaire; PQ-Likert Gen = Prodromal Questionnaire-Likert 
General Symptoms Subscale; Mood Pos = Current Positive Mood; Mood Neg = Current 
Negative Mood; sEBR = Spontaneous Eye Blink Rate 
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Figure 1. Model 2: Psychosis Risk and Mania Risk Model  
 
 
 
Note. CAPS = Cardiff Anomalous Perceptions Scale; PerAb = Perceptual Aberration 
Scale; MagicId = Magical Ideation Scale; PQ Pos = Prodromal Questionnaire-Likert 
Positive Symptoms Subscale; PID-5 = Personality Inventory for DSM-5 Psychoticism 
Domain; GBI = General Behavior Inventory; HPS = Hypomanic Personality Scale 
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Table 3  
Associations Between Risk Factors and Other Measures	
 
 Psychosis Risk Mania Risk 
Other Schizotypy   
SocAnh .37** -.05 
PQ-Likert Neg .68** .00 
PQ-Likert Disorg .85** -.11 
Manic-Like Episode Measures   
CIDI .09  .40** 
MDQ .14  .38** 
General Distress & Mood   
PQ-Likert Gen .36** .29** 
Mood Pos .03 -.07 
Mood Neg                     .02 .35** 
Physiological   
sEBR -.16* .17* 
 
Note. Associations with Model 2; *Correlation is significant at p < .05; **Correlation is 
significant at p < .01; SocAnh = Revised Social Anhedonia Scale; PQ-Likert Neg = 
Prodromal Questionnaire-Likert Negative Symptoms Subscale; PQ-Likert Disorg = 
Prodromal Questionnaire-Likert Disorganized Symptoms Subscale; CIDI = WHO CIDI 
3.0 Bipolar Screening Scales; MDQ = Mood Disorder Questionnaire; PQ-Likert Gen = 
Prodromal Questionnaire-Likert General Symptoms Subscale; Mood Pos = Current 
Positive Mood; Mood Neg = Current Negative Mood; sEBR = Spontaneous Eye Blink 
Rate  
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Supplemental Methods 
Weather Prediction Task (WPT). Participants completed the WPT (as in 
Karcher, Martin, & Kerns, 2015), as well as two additional versions of the task (i.e., 
Butterfly, and Mr. Potato Head). These two versions had the same underlying task 
structure but included different stimuli. In the Weather Prediction version of this task, 
participants needed to decide if it would rain or shine. They were shown four different 
cues or shapes, and each shape was associated with a fixed probability of either rain or 
shine. Participants were then shown combinations of one, two, or three of the possible 
shapes. Participants chose one of the possible outcomes (i.e., rain or shine) and then were 
given feedback after each choice. Based on this feedback, participants gradually learned 
how to respond in order to predict the most rewarded outcome. In the Butterfly version, 
participants were shown different colored butterflies and needed to predict if the butterfly 
would land on the purple or pink flower. In the Mr. Potato Head version, participants saw 
different facial features (i.e, hat, mustache, glasses, and ears) and needed to predict which 
ice cream (i.e., chocolate or vanilla) Mr. Potato Head would purchase. Participants 
completed all three versions of this task (i.e., WPT 1, WPT 2, and WPT3), with the order 
of versions randomized across participants. Each version consisted of 4 quartiles with 30 
trials in each.  
Analyses. Invalid trials (i.e., trials faster than 200 ms) were removed from 
analyses.  If 25% or more of the trials across the task were invalid or if 25% of more of 
the trials in the fourth quartile were invalid, then all of the participant’s responses for that 
specific WPT version were removed from analyses. After removing poor performers, 
data were analyzed for the remaining participants (WPT 1, n = 596; WPT 2, n = 534; 
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WPT 3, n = 456). For this task, accuracy was calculated by quartile. Additionally to 
assess learning, I calculated an accuracy difference score between the first and last 
quartiles for each version. 
Supplemental Results 
As can be seen in Supplementary Table 1, there was no learning effect across time 
on any of the WPT tasks. Additionally the WPT is a difficult task, and over time 
participants’ performance became quite poor, as indicated by more poor performers for 
WPT 2 and WPT 3. 
As can be seen in Supplementary Table 2, the difference scores for the WPT were 
not significantly correlated with any of the psychosis or mania risk scales.  Additionally, 
when accounting for shared variance, these scores were also not associated with either the 
psychosis risk or mania risk factors. However as performance was quite poor on these 
tasks, it is unclear if the current data could validly test the relationship between WPT 
learning with psychosis risk and mania risk.  
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Supplemental Table 1 
 
Weather Prediction Task Accuracy By Quartile 
 
     Accuracy     
  
N  
Quartile 1 
Mean (SD)  
Quartile 2 
Mean (SD)  
Quartile 3 
Mean (SD)  
Quartile 4 
Mean (SD) 
WPT 1 596  .55 (.13)  .60 (.14)  .61 (.15)  .61 (.15) 
WPT 2 534  .54 (.13)  .57 (.14)  .58 (.14)  .58 (.14) 
WPT 3 456  .54 (.12)  .57 (.14)  .57 (.14)  .57 (.14) 
 
Note. WPT = Weather Prediction Task
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Supplemental Table 2 
 
Zero-order Pearson Correlations and Associations Between Weather Prediction Task 
and Psychosis and Mania Risk 
 
 WPT 1 Difference WPT 2 Difference WPT 3 Difference 
Weather Prediction 
Task    
1. WPT 1 Difference —   
2. WPT 2 Difference .02 —  
3. WPT 3 Difference   .13**  .07 — 
Psychosis Scales    
4. PerAb .01  .01 -.06 
5. MagicId .03 -.02 -.04 
6. CAPS .02  .02  .01 
7. PQ-Likert Pos .01  .01 -.07 
8. PID-5 -.03 -.02 -.03 
Mania Scales    
9. GBI -.02 -.03  .01 
10. HPS .02 -.02  .02 
Risk Factors    
11. Psychosis Risk .05  .05 -.10 
12. Mania Risk -.05 -.07  .08 
 
Note. **Correlation is significant at p < .01; WPT = Weather Prediction Task; PerAb = 
Perceptual Aberration Scale; MagicId = Magical Ideation Scale; CAPS = Cardiff 
Anomalous Perceptions Scale; PQ-Likert Pos = Prodromal Questionnaire-Likert Positive 
Symptoms Subscale; PID-5 = Personality Inventory for DSM-5 Psychoticism Domain; 
HPS = Hypomanic Personality Scale; GBI = General Behavior Inventory 
 
